Targeting programmed cell death 1 receptor (PD-1) expression in lung cancer using a humanized mouse model

被引：0

作者：

Jiang, Dawei ^{[1
]}

England, Christopher ^{[1
]}

Ehlerding, Emily ^{[1
]}

Graves, Stephen ^{[2
]}

Hernandez, Reinier ^{[1
]}

Cai, Weibo ^{[1
]}

机构：

[1] Univ Wisconsin, Madison, WI USA

[2] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA

来源：

JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

179

引用

页数：2

共 50 条

[11] Programmed cell death protein 1 (PD-1) in infection
Leth, Steffen
Jensen-Fangel, Soren
APMIS, 2020, 128 (02) : 177 - 187
[12] ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES
Vidula, Neelima
Yau, Christina
Goga, Andrei
Rugo, Hope S.
BREAST, 2015, 24 : S67 - S68
[13] Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer
Ba, Yilmaz
Koc, Nermin
Helvac, Kaan
Kocak, Cem
Akdeniz, Rasit
Sahin, Havva Hande Keser
TRANSLATIONAL ONCOLOGY, 2021, 14 (02):
[14] Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model
Liu, Wai Nam
So, Wing Yan
Harden, Sarah L.
Fong, Shin Yie
Wong, Melissa Xin Yu
Tan, Wilson Wei Sheng
Tan, Sue Yee
Ong, Jessica Kai Lin
Rajarethinam, Ravisankar
Liu, Min
Cheng, Jia Ying
Suteja, Lisda
Yeong, Joe Poh Sheng
Iyer, N. Gopalakrishna
Lim, Darren Wan-Teck
Chen, Qingfeng
SCIENCE ADVANCES, 2022, 8 (47)
[15] Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics
Cassol, Clarissa A.
Owen, Dwight
Kendra, Kari
Braga, Juarez R.
Frankel, Wendy L.
Arnold, Christina A.
HISTOPATHOLOGY, 2020, 77 (02) : 240 - 249
[16] Programmed Death-1 (PD-1) Receptor/PD-1 Ligand (PD-L1) Expression in Fumarate Hydratase-Deficient Renal Cell Carcinoma
Alaghehbandan, Reza
Stehlik, Jan
Trpkov, Kiril
Magi-Galluzzi, Cristina
Foix, Maria Pane
Berney, Daniel
Sibony, Mathilde
Suster, Saul
Agaimy, Abbas
Montiel, Delia Perez
Pivovarcikova, Kristyna
Michalova, Kvetoslava
Daum, Ondrej
Ondic, Ondrej
Rotterova, Pavla
Michal, Michal
Hes, Ondrej
LABORATORY INVESTIGATION, 2017, 97 : 211A - 211A
[17] Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma
Alaghehbandan, Reza
Stehlik, Jan
Trpkov, Kiril
Magi-Galluzzi, Cristina
Mundo, Enric Condom
Foix, Maria Pane
Berney, Daniel
Sibony, Mathilde
Suster, Saul
Agaimy, Abbas
Montiel, Delia Perez
Pivovarcikova, Kristyna
Michalova, Kvetoslava
Daum, Ondrej
Ondic, Ondrej
Rotterova, Pavla
Dusek, Martin
Hora, Milan
Michal, Michal
Hes, Ondrej
ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 29 : 17 - 22
[18] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
Abaza, Abdelrahman
Idris, Faten Sid
Shaikh, Humna Anis
Vahora, Ilma
Moparthi, Kiran Prasad
Al Rushaidi, Majdah T.
Muddam, Meghana Reddy
Obajeun, Omobolanle A.
Jaramillo, Arturo P.
Khan, Safeera
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
[19] Targeting Programmed Cell Death-1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
Constantinidou, Anastasia
Alifieris, Constantinos
Trafalis, Dimitrios T.
PHARMACOLOGY & THERAPEUTICS, 2019, 194 : 84 - 106
[20] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER
Gulec, U. Kucukgoz
Bagir, E.
Paydas, S.
Seydaoglu, G.
Guzel, A. B.
Vardar, M. A.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1127 - 1127

← 1 2 3 4 5 →